Download FREE Sample
Overview
A mice model refers to a laboratory mouse utilized in scientific research focusing on the human diseases, genes, and responses to drug. Due to the similarities of mice with humans genetically, biologically, and behaviorally, mice have been established as model organisms in preclinical studies. These models would be either naturally occurring or genetically engineered (for example, knockout or transgenic) or humanized to better replicate a given disease condition. Thus, mice models are important for understanding the mechanism of a disease, as well as for drug discovery, evaluation of drug efficacy and safety, and in personalized medicine and therapeutic development.
To learn more about this report, download the PDF brochure
Increasing demand for personalized medicine to drive market growth
As the need for personalized medicine increases, the market for mice models is growing, as these require fine, predictive models that simulate human biological response. Genetically engineered mice including humanized models provide avenues to study individual genetic variations and disease mechanisms. It helps researchers to identify biomarkers, measure drug response of the patient, and better targeted therapies. Because of the growth in genomics and diagnostics measures, pharmaceutical and biotech industries rely more on mouse models to optimize preclinical testing, improve translational results, reduce clinical trial failures, and, ultimately, accelerate personalized treatment development.
Advancements in gene-editing (CRISPR/Cas9) - A key market trend
Adva"https://meditechinsights.com/gene-editing-market/">gene-editing technologies, particularly CRISPR/Cas9, have transformed the mice model market, by creating mutated mice fast and with precision and lower cost. These tools enable researchers to create knockout, knock-in, and humanized mice models that have the ability to mimic specific human genetic mutations and diseases with utmost accuracy. Such accuracy renders the mice model more relevant in preclinical studies, especially for complicated diseases like cancer, neurological disorders, and metabolic syndromes. Multiplex editing is another aspect that CRISPR enables, which allows the study of gene interactions. CRISPR-based gene editing is accelerating drug discovery, functional genomics, and personalized medicine research using mice models.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global mice model market is marked by the presence of established and emerging market players such as Charles River Laboratories, The Jackson Laboratory, Inotiv, genOway, Cyagen, Janvier Labs, Shanghai Model Organisms Center, Inc., Harbour BioMed, GemPharmatech, and Hera Biolabs; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 - 2030 |
| Growth Rate | ~9% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Model Type and Service, Technology, Application, End User |
| Regional Scope |
|
| Key Companies Mapped | Charles River Laboratories, The Jackson Laboratory, Inotiv, genOway, Cyagen, Janvier Labs, Shanghai Model Organisms Center, Inc., Harbour BioMed, GemPharmatech, and Hera Biolabs among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Mice Model Market Segmentation
This report by Medi-Tech Insights provides thesize of the global mice model market at theregional- and country-level from 2023 to 2030. The report further segments the market based on model type and service, technology, application, and end user.
Market Size & Forecast (2023-2030), By Model Type and Service, USD Million
- Model Type
- Inbred Mice
- Outbred Mice
- Genetically Modified Mice
- Hybrid Mice
- Services
- Cryopreservation
- Breeding
- Rederivation
- Quarantine
- Other Services
Market Size & Forecast (2023-2030), By Technology, USD Million
- CRISPR/Cas9
- Embryonic Stem Cell Injection
- Microinjection
- Nuclear Transfer >
Market Size & Forecast (2023-2030), By Application, USD Million
- Oncology
- Metabolic Diseases
- Immunology
- Neurology
- Cardiovascular Diseases
- Others
Market Size & Forecast (2023-2030), By End User, USD Million
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations (CROs)
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the mice model market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the mice model market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
Need a More Tailored Analysis?
- Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
- Expand the scope with additional countries, market segments, technologies, or competitor profiling.
- Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.
